← All companies

INCR

InterCure Ltd.

INCR Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.95

+0.00 +0.52%

Key statistics

from XBRL data in SEC filings

Market cap

$52.1M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.68 – $1.77

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K/A Jul 27, 2026 6-K Jul 22, 2026 6-K Jun 22, 2026 6-K Jun 15, 2026 6-K May 1, 2026 20-F Apr 30, 2026 6-K Mar 3, 2026 6-K Feb 19, 2026 6-K Dec 30, 2025 6-K Dec 18, 2025 6-K Nov 25, 2025 6-K Nov 3, 2025 6-K Oct 8, 2025 6-K Sep 19, 2025 6-K May 1, 2025 20-F May 1, 2025 6-K Feb 13, 2025 6-K Feb 3, 2025 6-K/A Jan 31, 2025 6-K Jan 27, 2025 6-K Dec 30, 2024 6-K Dec 20, 2024 6-K Dec 20, 2024 6-K Nov 25, 2024 6-K Nov 4, 2024 6-K Oct 28, 2024 6-K/A Sep 17, 2024 6-K Sep 13, 2024 6-K Aug 29, 2024 6-K Aug 28, 2024 6-K May 21, 2024 6-K May 1, 2024 20-F May 1, 2024 6-K Apr 1, 2024 6-K Feb 13, 2024 6-K Feb 13, 2024 6-K Jan 31, 2024 6-K Dec 14, 2023 6-K Nov 8, 2023 6-K Oct 31, 2023